COMMUNIQUÉS West-GlobeNewswire

Progenics Acquires AZEDRA® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility
11/02/2019
NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]
PSIQ Forms CannBerry Tek to Develop a Cannabis Genetic Seed Bank to Create Proprietary Cannabis Seed Types and Strains
11/02/2019
SUNRISE, Fla., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces the formation of CannBerry Tek, Inc. as a Hi-tech innovative Biotechnology Company to manage various Research & [...]
Advantis Corp. Moves Forward with Plans to Establish Los Angeles Presence, Partners with Statewide Distributor and Manufacturer
11/02/2019
NEWPORT BEACH, CA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that it is resuming negotiations to establish a location in Los Angeles to package and [...]
AIT Therapeutics Announces Appointment of Robert F. Carey to Board of Directors
11/02/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, Feb. 11, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
Lumere Closes Strategic Growth Capital Funding
11/02/2019
Investment Led by Heritage Group with Participation from Clients Spectrum Health Ventures and HCA Healthcare CHICAGO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Lumere, Inc., a leading provider of evidence-based analytics and [...]
Active Biotech's partner NeoTX enters clinical collaboration with AstraZeneca to evaluate ANYARA in combination with IMFINZI® (durvalumab) in the upcoming Phase 1b/2 study
11/02/2019
PRESS RELEASE Lund Sweden, February 11 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that their partner NeoTX enters a clinical collaboration with AstraZeneca Group Plc (NYSE: AZN) global biologics research [...]
Eton Pharmaceuticals Enters Into License Agreement for Two Branded Hospital Product Candidates
11/02/2019
Transaction adds an additional potential 2019 product launch to Eton’s pipeline ET-202 NDA was submitted in December 2018; PDUFA date expected to be in Q4 2019 ET-203 NDA expected to be submitted by Q3 2019 DEER PARK, [...]
Nemaura Announces Dr. Fred Schaebsdau to Lead Strategy and Business Development
11/02/2019
Dr. Schaebsdau to Advance European Launch of SugarBEAT ® Continuous Glucose Monitor Nemaura Preparing U.S. FDA 510(k) Submission Loughborough, England – February 11, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD) [...]
CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer
11/02/2019
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer Cambridge, UK, 11 February 2019 : CMR Surgical Ltd, the British company developing [...]
Delcath Announces Health Authority Approval for CHEMOSAT in Brazil
11/02/2019
Discussions Underway With Potential Commercialization Partners NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and [...]
IntelGenx Granted Japanese Patent for RIZAPORT® VersaFilm™
11/02/2019
SAINT LAURENT, Quebec, Feb. 11, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has received a Decision to Grant notice from [...]
CLS Holdings USA Inc. Included in LD Micro Index Rebalance
11/02/2019
LAS VEGAS, Feb. 11, 2019 (GLOBE NEWSWIRE) -- CLS Holdings USA Inc. (OTCQB:CLSH) (CSE:CLSH.U) “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce that it has been included in [...]
BLOCKStrain Taps into the CBD Beverage Industry with NXT Water Deal -- CFN Media
11/02/2019
SEATTLE, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Allakos Announces Positive Phase 2 Results for AK002 in Patients with Xolair Refractory Chronic Spontaneous Urticaria and Provides Additional Data from Chronic Urticaria Study Cohorts
11/02/2019
-- 55% (6/11) response rate by UCT in Xolair Refractory CSU patients -- -- 49% reduction in UAS7 in Xolair Refractory CSU patients -- -- 77% (10/13) complete hive response by HSS7 in Xolair Naïve CSU patients -- -- 54 [...]
Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY (ipilimumab) for the Treatment of Relapsed and Refractory Melanoma
11/02/2019
BERKELEY, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that the first patient has been dosed in a Phase 1 trial of ADU-S100 (MIW815), a novel stimulator of interferon [...]
Tauriga Sciences, Inc. Implements Quality Assurance Protocols Within the Manufacturing Process of its CBD Infused Gum
11/02/2019
NEW YORK, NY, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial
11/02/2019
-- Substudy promptly accrued 36 patients in less than six months, with majority of newly enrolled patients receiving low-dose steroids -- BOSTON, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) [...]
Theratechnologies Appoints General Manager in Europe
11/02/2019
MONTREAL, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that its European subsidiary, Theratechnologies International Limited, has appointed Mr. Conor [...]
Theratechnologies Nomme un Directeur Général en Europe
11/02/2019
MONTRÉAL, 11 févr. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que sa filiale européenne, Theratechnologies International Limitée, a nommé M. Conor Walshe à [...]

Pages